...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Hand Surgery. American Volume >Long-term results of vascularized bone graft for stage III Kienb?ck disease
【24h】

Long-term results of vascularized bone graft for stage III Kienb?ck disease

机译：血管化骨移植治疗Ⅲ期肯尼贝克病的长期结果

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Purpose: Vascularized bone grafting (VBG) is one of the therapeutic approaches for treating advanced Kienb?ck disease; however, few reports on long-term outcomes are available for this technique. The purpose of this study is to evaluate long-term results by following up patients with stage III Kienb?ck disease for more than 10 years after VBG. Methods: The study included 18 patients with advanced Kienb?ck disease (Lichtman stage IIIA, n = 10; stage IIIB, n = 8) who received VBG between 1996 and 2001 and were followed up for at least 10 years. Eleven patients received transplantation from the metacarpal base and 7 patients from the distal radius. Radial shortening and capitate shortening were performed in 5 and 2 stage IIIB patients, respectively. Results: The mean follow-up period was 12 years, 3 months. Based on the Mayo Modified Wrist Score, clinical results were excellent in 8 patients, good in 7 patients, and fair in 3 patients. The Stahl index and carpal height ratio were not improved in stage IIIA patients who received bone graft alone, whereas significant improvement was observed in stage IIIB patients who received shortening, as well. Conclusions: Vascularized bone grafting for stage III Kienb?ck disease demonstrated favorable long-term results and is recommended as a surgical treatment. Type of study/level of evidence: Therapeutic III.
机译：目的：血管化植骨（VBG）是治疗晚期肯尼贝克病的一种治疗方法。但是，很少有关于这种技术的长期结果的报告。这项研究的目的是通过对VBG术后10余年的KienbackⅢ期患者进行随访来评估长期结果。方法：该研究包括1996年至2001年间接受VBG的18例晚期肯尼贝克病（Lichtman IIIA期，n = 10; IIIB期，n = 8），并至少随访了10年。 11名患者从掌骨基地接受了移植，7名患者从radius骨远端接受了移植。分别在5名和2名IIIB期患者中进行了shorten骨缩短和头缩短。结果：平均随访期为12年3个月。根据Mayo改良手腕评分，8例患者的临床结果优异，7例患者的临床结果良好，3例患者的临床结果良好。仅接受骨移植的IIIA期患者的Stahl指数和腕高比没有改善，而接受缩短的IIIB期患者也观察到了显着的改善。结论：血管化植骨治疗Ⅲ期肯尼贝克病具有良好的长期效果，推荐用于外科治疗。研究类型/证据级别：治疗III。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号